These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38704228)

  • 1. Metrics of uterine myomatosis symptomatology in clinical practice.
    Hudeček R; Mekiňová L; Šimová S; Bánovská L; Hledíková A
    Ceska Gynekol; 2024; 89(2):144-150. PubMed ID: 38704228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Spanish version of the Uterine Fibroid Symptom and Quality of Life (UFS-QoL) questionnaire in women with uterine myomatosis.
    Calaf J; Palacios S; Cristóbal I; Cañete ML; Monleón J; Fernández J; Hernández A; Vázquez F
    Med Clin (Barc); 2020 Mar; 154(6):207-213. PubMed ID: 31685223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relugolix combination therapy and symptoms of uterine myomatosis - selected case reports of indication spectrum and treatment outcomes.
    Hudeček R; Klát J; Pohl K; Prokopenko A; Mikulášek L; Šimová S; Krčál P; Ševčík A; Tomeš P
    Ceska Gynekol; 2023; 88(5):359-370. PubMed ID: 37932053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of uterine myoma].
    Török P; Póka R
    Orv Hetil; 2016 May; 157(21):813-9. PubMed ID: 27177787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine fibroids associated with infertility.
    Van Heertum K; Barmat L
    Womens Health (Lond); 2014 Nov; 10(6):645-53. PubMed ID: 25482490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Bleeding and Pelvic Discomfort Scale for Use in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
    Hudgens S; Gauthier M; Hunsche E; Kang J; Li Y; Scippa K; As-Sanie S
    Value Health; 2022 Dec; 25(12):1986-1994. PubMed ID: 35863945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey).
    Koga K; Fukui M; Fujisawa M; Suzukamo Y
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine Fibroid Morphology and Histology with Respect to Reproductive Age.
    Hudecek R; Huser M; Jandakova E; Mekinova L; Kadlecova J; Ventruba P
    J Reprod Med; 2016 Sep; 61(9-10):476-482. PubMed ID: 30383948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of uterine myomas and clinical practice in Spain: An observational study.
    Monleón J; Cañete ML; Caballero V; Del Campo M; Doménech A; Losada MÁ; Calaf J;
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():59-65. PubMed ID: 29852335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of transcervical resection of submucous fibroids on menstrual blood loss: A prospective cohort study.
    Keizer AL; Jacobs BL; Thurkow AL; de Lange ME; Radder CM; van Kesteren PJM; Hanstede MMF; Huirne JAF; Hehenkamp WJK
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():128-135. PubMed ID: 35640441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology of myomatosis uteri: the underlying knowledge to support our clinical practice.
    Torres-de la Roche LA; Becker S; Cezar C; Hermann A; Larbig A; Leicher L; Di Spiezio Sardo A; Tanos V; Wallwiener M; Verhoeven H; De Wilde RL
    Arch Gynecol Obstet; 2017 Oct; 296(4):701-707. PubMed ID: 28864872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroids and Fertility.
    Alkhrait S; Malasevskaia I; Madueke-Laveaux OS
    Obstet Gynecol Clin North Am; 2023 Dec; 50(4):663-675. PubMed ID: 37914486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine myomas in adolescents: case reports and a review of the literature.
    Fields KR; Neinstein LS
    J Pediatr Adolesc Gynecol; 1996 Nov; 9(4):195-8. PubMed ID: 8957774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study.
    Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC
    Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of uterine myomatosis].
    Federación Mexicana de Colegios de Obstetricia y Ginecología
    Ginecol Obstet Mex; 2011 Nov; 79(11):711-8. PubMed ID: 22168118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.